Stable formulations, useful e.g. for treating hyperlipidemia and hypertension, comprise statin and angiotensin converting enzyme inhibitor separated by inert material

摘要

Formulations (A) comprise statin(s) (I) and angiotensin converting enzyme (ACE) inhibitor(s) (II), where (I) and (II) are separated by inert material (III).